350 related articles for article (PubMed ID: 31694035)
1. The Application of Magnetic Resonance Imaging-Deformed 11C-Methionine-Positron Emission Tomography Images in Stereotactic Radiosurgery.
Jung TY; Jung S; Ryu HS; Kim IY; Jang WY; Moon KS; Lim SH; Kim DY; Kang SR; Min JJ; Bom HS; Kim SK; Kwon SY
Stereotact Funct Neurosurg; 2019; 97(4):217-224. PubMed ID: 31694035
[TBL] [Abstract][Full Text] [Related]
2. Quantitative Feasibility Evaluation of 11C-Methionine Positron Emission Tomography Images in Gamma Knife Radiosurgery : Phantom-Based Study and Clinical Application.
Lim SH; Jung TY; Jung S; Kim IY; Moon KS; Kwon SY; Jang WY
J Korean Neurosurg Soc; 2019 Jul; 62(4):476-486. PubMed ID: 31154754
[TBL] [Abstract][Full Text] [Related]
3. A fully automatic approach for multimodal PET and MR image segmentation in gamma knife treatment planning.
Rundo L; Stefano A; Militello C; Russo G; Sabini MG; D'Arrigo C; Marletta F; Ippolito M; Mauri G; Vitabile S; Gilardi MC
Comput Methods Programs Biomed; 2017 Jun; 144():77-96. PubMed ID: 28495008
[TBL] [Abstract][Full Text] [Related]
4. Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: is a differential diagnosis possible?
Tsuyuguchi N; Sunada I; Iwai Y; Yamanaka K; Tanaka K; Takami T; Otsuka Y; Sakamoto S; Ohata K; Goto T; Hara M
J Neurosurg; 2003 May; 98(5):1056-64. PubMed ID: 12744366
[TBL] [Abstract][Full Text] [Related]
5. Clinical value of [¹¹C]methionine PET for stereotactic radiation therapy with intensity modulated radiation therapy to metastatic brain tumors.
Miwa K; Matsuo M; Shinoda J; Aki T; Yonezawa S; Ito T; Asano Y; Yamada M; Yokoyama K; Yamada J; Yano H; Iwama T
Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1139-44. PubMed ID: 22520479
[TBL] [Abstract][Full Text] [Related]
6. Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery--in malignant glioma.
Tsuyuguchi N; Takami T; Sunada I; Iwai Y; Yamanaka K; Tanaka K; Nishikawa M; Ohata K; Torii K; Morino M; Nishio A; Hara M
Ann Nucl Med; 2004 Jun; 18(4):291-6. PubMed ID: 15359921
[TBL] [Abstract][Full Text] [Related]
7. Effect of 11C-methionine-positron emission tomography on gross tumor volume delineation in stereotactic radiotherapy of skull base meningiomas.
Astner ST; Dobrei-Ciuchendea M; Essler M; Bundschuh RA; Sai H; Schwaiger M; Molls M; Weber WA; Grosu AL
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1161-7. PubMed ID: 18440729
[TBL] [Abstract][Full Text] [Related]
8. Clinical benefit of 11C methionine PET imaging as a planning modality for radiosurgery of previously irradiated recurrent brain metastases.
Momose T; Nariai T; Kawabe T; Inaji M; Tanaka Y; Watanabe S; Maehara T; Oda K; Ishii K; Ishiwata K; Yamamoto M
Clin Nucl Med; 2014 Nov; 39(11):939-43. PubMed ID: 25140562
[TBL] [Abstract][Full Text] [Related]
9. 11C-methionine PET improves the target volume delineation of meningiomas treated with stereotactic fractionated radiotherapy.
Grosu AL; Weber WA; Astner ST; Adam M; Krause BJ; Schwaiger M; Molls M; Nieder C
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):339-44. PubMed ID: 16765533
[TBL] [Abstract][Full Text] [Related]
10. Differentiation between Treatment-Induced Necrosis and Recurrent Tumors in Patients with Metastatic Brain Tumors: Comparison among
Tomura N; Kokubun M; Saginoya T; Mizuno Y; Kikuchi Y
AJNR Am J Neuroradiol; 2017 Aug; 38(8):1520-1527. PubMed ID: 28619837
[TBL] [Abstract][Full Text] [Related]
11. Whole-tumor histogram analysis of the cerebral blood volume map: tumor volume defined by 11C-methionine positron emission tomography image improves the diagnostic accuracy of cerebral glioma grading.
Wu R; Watanabe Y; Arisawa A; Takahashi H; Tanaka H; Fujimoto Y; Watabe T; Isohashi K; Hatazawa J; Tomiyama N
Jpn J Radiol; 2017 Oct; 35(10):613-621. PubMed ID: 28879406
[TBL] [Abstract][Full Text] [Related]
12. Use of stereotactic PET images in dosimetry planning of radiosurgery for brain tumors: clinical experience and proposed classification.
Levivier M; Massager N; Wikler D; Lorenzoni J; Ruiz S; Devriendt D; David P; Desmedt F; Simon S; Van Houtte P; Brotchi J; Goldman S
J Nucl Med; 2004 Jul; 45(7):1146-54. PubMed ID: 15235060
[TBL] [Abstract][Full Text] [Related]
13. Validation of a method for automatic image fusion (BrainLAB System) of CT data and 11C-methionine-PET data for stereotactic radiotherapy using a LINAC: first clinical experience.
Grosu AL; Lachner R; Wiedenmann N; Stärk S; Thamm R; Kneschaurek P; Schwaiger M; Molls M; Weber WA
Int J Radiat Oncol Biol Phys; 2003 Aug; 56(5):1450-63. PubMed ID: 12873691
[TBL] [Abstract][Full Text] [Related]
14. Impact of 11C-methionine positron emission tomography/computed tomography on radiation therapy planning and prognosis in patients with primary brain tumors.
Schinkelshoek M; Lopci E; Clerici E; Alongi F; Mancosu P; Rodari M; Navarria P; van der Hiel B; Scorsetti M; Chiti A
Tumori; 2014; 100(6):636-44. PubMed ID: 25688497
[TBL] [Abstract][Full Text] [Related]
15. Target definition by C11-methionine-PET for the radiotherapy of brain metastases.
Matsuo M; Miwa K; Shinoda J; Kako N; Nishibori H; Sakurai K; Yano H; Iwama T; Kanematsu M
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):714-22. PubMed ID: 19095373
[TBL] [Abstract][Full Text] [Related]
16. Integrated positron emission tomography and magnetic resonance imaging-guided resection of brain tumors: a report of 103 consecutive procedures.
Pirotte B; Goldman S; Dewitte O; Massager N; Wikler D; Lefranc F; Ben Taib NO; Rorive S; David P; Brotchi J; Levivier M
J Neurosurg; 2006 Feb; 104(2):238-53. PubMed ID: 16509498
[TBL] [Abstract][Full Text] [Related]
17. Delineation of brain tumor extent with [11C]L-methionine positron emission tomography: local comparison with stereotactic histopathology.
Kracht LW; Miletic H; Busch S; Jacobs AH; Voges J; Hoevels M; Klein JC; Herholz K; Heiss WD
Clin Cancer Res; 2004 Nov; 10(21):7163-70. PubMed ID: 15534088
[TBL] [Abstract][Full Text] [Related]
18. Use of (11)C-methionine PET parametric response map for monitoring WT1 immunotherapy response in recurrent malignant glioma.
Chiba Y; Kinoshita M; Okita Y; Tsuboi A; Isohashi K; Kagawa N; Fujimoto Y; Oji Y; Oka Y; Shimosegawa E; Morita S; Hatazawa J; Sugiyama H; Hashimoto N; Yoshimine T
J Neurosurg; 2012 Apr; 116(4):835-42. PubMed ID: 22242671
[TBL] [Abstract][Full Text] [Related]
19. 11C-methionine-18F-FDG dual-PET-tracer-based target delineation of malignant glioma: evaluation of its geometrical and clinical features for planning radiation therapy.
Hirata T; Kinoshita M; Tamari K; Seo Y; Suzuki O; Wakai N; Achiha T; Umehara T; Arita H; Kagawa N; Kanemura Y; Shimosegawa E; Hashimoto N; Hatazawa J; Kishima H; Teshima T; Ogawa K
J Neurosurg; 2019 Sep; 131(3):676-686. PubMed ID: 30239314
[TBL] [Abstract][Full Text] [Related]
20. l-[METHYL-(11)C] methionine positron emission tomography for target delineation in malignant gliomas: impact on results of carbon ion radiotherapy.
Mahasittiwat P; Mizoe JE; Hasegawa A; Ishikawa H; Yoshikawa K; Mizuno H; Yanagi T; Takagi R; Pattaranutaporn P; Tsujii H
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):515-22. PubMed ID: 17900820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
